Short stature due to endocrine disorder, unspecified
ICD-10 E34.30 is a billable code used to indicate a diagnosis of short stature due to endocrine disorder, unspecified.
Short stature due to endocrine disorder, unspecified, refers to a condition where an individual exhibits a height significantly below the average for their age and sex, attributed to an underlying endocrine dysfunction. This can include disorders related to growth hormone deficiency, thyroid dysfunction, adrenal insufficiency, or other hormonal imbalances. In children, short stature can be a result of delayed puberty, where the onset of secondary sexual characteristics is postponed, impacting growth patterns. Polyglandular dysfunction, where multiple endocrine glands fail to function properly, can also contribute to short stature. Thymus disorders, while primarily affecting immune function, can indirectly influence growth through hormonal pathways. Growth abnormalities may arise from genetic factors or environmental influences, but when classified under E34.30, the specific endocrine cause remains unspecified. Accurate diagnosis and management are crucial, as treatment may involve hormone replacement therapy or addressing the underlying endocrine disorder to promote normal growth and development.
Growth charts, detailed patient history, and endocrine evaluations.
Evaluation of children presenting with short stature and delayed puberty.
Ensure all relevant growth parameters are documented, including familial height patterns.
Comprehensive hormonal assessments and imaging studies.
Management of patients with suspected endocrine disorders affecting growth.
Document all lab results and treatment plans to support coding.
Used to evaluate suspected growth hormone deficiency in children with short stature.
Document the indication for the test and results.
Endocrinologists should ensure comprehensive documentation of the patient's growth history.
E34.30 is significant as it captures cases of short stature due to unspecified endocrine disorders, allowing for appropriate management and treatment planning. It highlights the need for further evaluation to determine the specific underlying cause.
